Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Norina Tanaka
Observed name:
N. Tanaka
Institution:
Tokyo Women's Medical University
Observed institutions:
Tokyo Women's Medical University Hospital,
Tokyo Women's Medical University,
Heinrich Heine University Düsseldorf
ORCID:
0000-0002-8378-540X
Observed ORCID:
0000-0002-8378-540X
OpenAlex ID:
A5011532171
Works
35
Awards
1
Clinical impact of serum soluble SLAMF7 in multiple myeloma
2018
·
Mariko Ishibashi
, Saori Soeda
, et al.
·
Oncotarget
·
57
PDF
L265P Mutation of the MYD88 Gene Is Frequent in Waldenström’s Macroglobulinemia and Its Absence in Myeloma
2013
·
Naoki Mori
, Mari Ohwashi
, et al.
·
PLoS ONE
·
43
PDF
Inhibition of PRAME expression causes cell cycle arrest and apoptosis in leukemic cells
2011
·
Norina Tanaka
, Yan-Hua Wang
, et al.
·
Leukemia Research
·
42
Phase I study of cellular therapy using ex vivo expanded natural killer cells from autologous peripheral blood mononuclear cells combined with rituximab-containing chemotherapy for relapsed CD20-positive malignant lymphoma patients
2019
·
Junji Tanaka
, Norina Tanaka
, et al.
·
Haematologica
·
24
PDF
SLAMF3-Mediated Signaling via ERK Pathway Activation Promotes Aggressive Phenotypic Behaviors in Multiple Myeloma
2020
·
Mariko Ishibashi
, Risa Takahashi
, et al.
·
Molecular Cancer Research
·
22
PDF
Circulating cell-free DNA in the peripheral blood plasma of patients is an informative biomarker for multiple myeloma relapse
2021
·
Hiroshi Yasui
, Masayuki Kobayashi
, et al.
·
International Journal of Clinical Oncology
·
14
Elotuzumab Enhances CD16‐Independent NK Cell‐Mediated Cytotoxicity against Myeloma Cells by Upregulating Several NK Cell‐Enhancing Genes
2024
·
Yan-Hua Wang
, Shotaro Hagiwara
, et al.
·
Journal of Immunology Research
·
11
PDF
Level of DNA topoisomerase IIα mRNA predicts the treatment response of relapsed acute leukemic patients
2009
·
Yan-Hua Wang
, Minoko Takanashi
, et al.
·
Leukemia Research
·
10
Very Early Increased Platelet Count within a Week after Initiation of High-Dose Dexamethasone Treatment Is Associated with Long-Term Response in Newly Diagnosed Immune Thrombocytopenia Patients
2021
·
Midori Ishiyama
, Masayuki Shiseki
, et al.
·
Acta Haematologica
·
7
Successful Rituximab Treatment in Thrombotic Thrombocytopenic Purpura Patients Complicated by Other Autoimmune Disorders: Two Case Reports
2021
·
Aya Watanabe
, Masayuki Shiseki
, et al.
·
Internal Medicine
·
5
PDF
Fractionated ifosfamide, carboplatin, and etoposide with rituximab as a safe and effective treatment for relapsed/refractory diffuse large B cell lymphoma with severe comorbidities
2020
·
Norina Tanaka
, Yoichi Imai
, et al.
·
Annals of Hematology
·
5
The levels of serum soluble CD86 are correlated with the expression of CD86 variant 3 gene and are prognostic indicators in patients with myeloma
2023
·
Ryosuke Kinoshita
, Mariko Ishibashi
, et al.
·
Experimental Hematology
·
4
PDF
Individual HLAs influence immunological events in allogeneic stem cell transplantation from HLA-identical sibling donors
2020
·
Satoko Morishima
, Takahiro Fukuda
, et al.
·
Bone Marrow Transplantation
·
4
High PRAME expression is associated with poor survival and early disease progression in myelodysplastic syndromes with a low bone marrow blast percentage
2021
·
Masayuki Shiseki
, Mayuko Ishii
, et al.
·
Leukemia & lymphoma/Leukemia and lymphoma
·
3
Herpes zoster after autologous haematopoietic stem cell transplantation without antiviral prophylaxis
2019
·
Akihito Shinohara
, Satoko Osanai
, et al.
·
British Journal of Haematology
·
3
PDF
[Usefulness of (18)F-FDG PET/CT for detecting lesions in patients with POEMS syndrome].
2012
·
Norina Tanaka
, Kentaro Yoshinaga
, et al.
·
PubMed
·
3
The Limited Impact of Pre-existing Rheumatologic Diseases on Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation: A Nationwide Propensity–Score Matched Analysis
2025
·
Norina Tanaka
, Akihito Shinohara
, et al.
·
Transplantation and Cellular Therapy
·
2
Ex-Vivo Expanded NK Cell Therapy Combined with Elotuzumab for MRD after Autologous Stem Cell Transplantation: A Phase I/ II Clinical Trial in Progress
2019
·
Shotaro Hagiwara
, Yan-Hua Wang
, et al.
·
Blood
·
1
Clinical Features of Post-Transplant Lymphoproliferative Disease Are Different between Kidney-Transplant Recipients from a Cadaveric Donor and Those from a Living Donor
2019
·
Shoko Oshima
, Akihito Shinohara
, et al.
·
Blood
·
1
Retrospective Analysis of Treatment Outcomes for Patients with Follicular Lymphoma and Comorbidities
2015
·
Aya Watanabe
, Yoichi Imai
, et al.
·
Blood
·
1
Fractionated ICE with Rituximab Is Safe and Effective for Relapse/Refractory DLBCL Patients with Severe Comorbidities
2015
·
Norina Tanaka
, Yoichi Imai
, et al.
·
Blood
·
1
Supplementary Tables S1 to S5 and Supplemental Figures 1 to 15 from SLAMF3-Mediated Signaling via ERK Pathway Activation Promotes Aggressive Phenotypic Behaviors in Multiple Myeloma
2023
·
Mariko Ishibashi
, Risa Takahashi
, et al.
Data from SLAMF3-Mediated Signaling via ERK Pathway Activation Promotes Aggressive Phenotypic Behaviors in Multiple Myeloma
2023
·
Mariko Ishibashi
, Risa Takahashi
, et al.
Data from SLAMF3-Mediated Signaling via ERK Pathway Activation Promotes Aggressive Phenotypic Behaviors in Multiple Myeloma
2023
·
Mariko Ishibashi
, Risa Takahashi
, et al.
[Effective therapy with cyclophosphamide, doxorubicin, vincristine, and prednisolone chemotherapy with obinutuzumab for follicular lymphoma in leukemic phase].
2023
·
Satoko Osanai
, Shoko Oshima
, et al.
·
PubMed
Show more works
View as search
Works count:
35
Citation count:
263
H-index:
8
I10-index:
8
Year
Topic
Type